Snap-8
A synthetic cosmetic octapeptide marketed topically as a SNAP-25 mimetic to soften expression lines; evidence is formulation-level.
Overview
Snap-8 (acetyl octapeptide-3) is a synthetic cosmetic peptide marketed as a topical anti-wrinkle ingredient. It is designed to mimic an N-terminal region of SNAP-25, a protein involved in neurotransmitter release, with the goal of reducing contraction-driven expression lines. It is a cosmetic ingredient rather than a systemically acting drug.
Mechanism
By competing with SNAP-25 in the SNARE complex, the peptide is proposed to partially inhibit vesicle fusion and acetylcholine release at the neuromuscular junction, producing a botulinum-toxin-like softening of muscle contraction. Direct proof of this mechanism in intact skin is limited, and independent mechanistic studies are sparse.
Expected Effects
- Marketing and formulation studies claim reduced depth of expression lines with topical use
- Effects are intended to be milder and shorter-lived than botulinum toxin injections
- Independent peer-reviewed confirmation is limited
Side Effects & Tolerability
Designed for topical cosmetic use; local irritation or sensitization is the main reported concern. Systemic effects are not expected at cosmetic-use concentrations.
Storage
Store raw peptide cold and desiccated; finished cosmetic formulations follow normal cosmetic stability practice.